The slowly aggregating salmon Calcitonin: A useful tool for the study of the amyloid oligomers structure and activity

International Journal of Molecular Sciences

Volumn 12, Issue 12, 2011, Pages 9277-9295

  Diociaiuti, Marco ^a   Gaudiano, Maria Cristina ^a   Malchiodi Albedi, Fiorella ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Aggregation; Amyloid oligomers; Lipid rafts

Indexed keywords

AMYLOID; CALCIUM ION; HYDROGEN PEROXIDE; LIPOSOME; OLIGOMER; SALCATONIN; CALCITONIN; FISH PROTEIN;

CALCIUM TRANSPORT; CELL MEMBRANE PERMEABILITY; CELL PERMEABILIZATION; CELL TYPE; CIRCULAR DICHROISM; CONFORMATIONAL TRANSITION; CYTOTOXICITY; LIPID RAFT; MOLECULAR WEIGHT; NERVE CELL CULTURE; NONHUMAN; OXIDATION KINETICS; PROTEIN AGGREGATION; PROTEIN CONFORMATION; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LIPID INTERACTION; PROTEIN PROCESSING; PROTEIN SECONDARY STRUCTURE; REVIEW; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; CELL MEMBRANE; METABOLISM; NERVE CELL; PROTEINOSIS; SALMON; ULTRASTRUCTURE;

AMYLOID; ANIMALS; CALCITONIN; FISH PROTEINS; MEMBRANE MICRODOMAINS; NEURONS; PROTEIN AGGREGATION, PATHOLOGICAL; SALMON;

EID: 84055193834     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms12129277     Document Type: Review

References (49)

1. Glenner, G.G.; Wong, C.W. Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein. Biochem. Biophys. Res. Commun. 1984, 122, 1131-1135.
2. DeArmond, S.J.; McKinley, M.P.; Barry, R.A. Identification of prion amyloid filaments in scrapieinfected brain. Cell 1985, 41, 221-235.
3. Spillantini, M.G.; Crowther, R.A.; Jakes, R.; Hasegawa, M.; Goedert, M. α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies Proc. Natl. Acad. Sci. USA 1998, 95, 6469-6473.
4. Schnabel, J. Protein folding: The dark side of proteins. Nature 2010, 464, 828-829.
5. Goldschmidt, L.; Teng, P.K.; Riek, R.; Eisenberg, D. Identifying the amylome, proteins capable of forming amyloid-like fibrils. Proc. Natl. Acad. Sci. USA 2010, 107, 3487-3492.
6. Lambert, M.P.; Barlow, A.K.; Chromy, B.A.; Edwards, C.; Freed, R.; Liosatos, M.; Morgan, T.E.; Rozovsky, I.; Trommer, B.; Viola, K.L.; et al. Diffusible, nonfibrillar ligands derived from abeta1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. USA 1998, 95, 6448-6453.
7. Walsh, D.M.; Klyubin, I.; Fadeeva, J.V.; Cullen, W.K.; Anwyl, R.; Wolfe, M.S.; Rowan, M.J.; Selkoe, D.J. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 2002, 416, 535-553.
8. Lashuel, H.A.; Grillo-Bosch, D. In vitro preparation of prefibrillar intermediates of amyloid-beta and alfa-synuclein. Methods Mol. Biol. 2005, 299, 19-33.
9. Lashuel, H.A.; Hartley, D.; Petre, B.M.; Walz, T.; Lansbury, P.T., Jr. Neurodegenerative disease: Amyloid pores from pathogenic mutations. Nature 2002, 418, 291.
10. Bucciantini, M.; Giannoni, E.; Chiti, F.; Baroni, F.; Formigli, L.; Zurdo, J.; Taddei, N.; Ramponi, G.; Dobson, C.M.; Stefani, M. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 2002, 416, 507-511.
11. Kayed, R.; Head, E.; Thompson, J.L.; McIntire, T.M.; Milton, S.C.; Cotman, C.W.; Glabe, C.G. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 2003, 300, 486-489.
12. Quist, A.; Doudevski, I.; Lin, H.; Azimova, R.; Ng, D.; Frangione, B.; Kagan, B.; Ghiso, J.; Lal, R. Amyloid ion channels: A common structural link for protein-misfolding disease. Proc. Natl. Acad. Sci. USA 2005, 102, 10427-10432.
13. Lashuel, H.A.; Lansbury, P.T., Jr. Are amyloid diseases caused by protein aggregates that mimic bacterial pore-forming toxins? Q. Rev. Biophys. 2006, 39, 167-201.
14. Glabe, C.G. Common mechanisms of amyloid oligomer pathogenesis in degenerative disease. Neurobiol. Aging 2006, 27, 570-575.
15. Kagan, B.L.; Azimov, R.; Azimova, R. Amyloid peptide channels. J. Membr. Biol. 2004, 202, 1-10.
16. Volles, M.J.; Lansbury, P.T., Jr. Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease. Biochemistry 2003, 42, 7871-7878.
17. Rochet, J.C.; Outeiro, T.F.; Conway, K.A.; Ding, T.T.; Volles, M.J.; Lashuel, H.A.; Bieganski, R.M.; Lindquist, S.L.; Lansbury, P.T. Interactions among alpha-synuclein, dopamine, and biomembranes: Some clues for understanding neurodegeneration in Parkinson's disease. J. Mol. Neurosci. 2004, 23, 23-34.
18. Lin, H.; Bhatia, R.; Lal, R. Amyloid beta protein forms ion channels: Implications for Alzheimer's disease pathophysiology. FASEB J. 2001, 15, 2433-2444.
19. Durell, S.R.; Guy, H.R.; Arispe, N.; Rojas, E.; Pollard, H.B. Theoretical models of the ion channel structure of amyloid beta-protein. Biophys. J. 1994, 67, 2137-2145.
20. Shafrir, Y.; Durell, S.R.; Anishkin, A.; Guy, H.R. Beta-barrel models of soluble amyloid beta oligomers and annular protofibrils. Proteins 2010, 78, 3458-3472.
21. Shafrir, Y.; Durell, S.; Arispe, N.; Guy, H.R. Models of membrane-bound Alzheimer's abeta peptide assemblies. Proteins 2010, 78, 3473-3487.
22. Jang, H.; Zheng, J.; Nussinov, R. Models of beta-amyloid ion channels in the membrane suggest that channel formation in the bilayer is a dynamic process. Biophys. J. 2007, 93, 1938-1949.
23. Kakio, A.; Nishimoto, S.I.; Yanagisawa, K.; Kozutsumi, Y.; Matsuzaki, K. Cholesterol-dependent formation of gm1 ganglioside-bound amyloid beta-protein, an endogenous seed for Alzheimer amyloid. J. Biol. Chem. 2001, 276, 24985-24990.
24. Kakio, A.; Nishimoto, S.; Yanagisawa, K.; Kozutsumi, Y.; Matsuzaki, K. Interactions of amyloid beta-protein with various gangliosides in raft-like membranes: Importance of gm1 ganglioside-bound form as an endogenous seed for Alzheimer amyloid. Biochemistry 2002, 41, 7385-7390.
25. Simons, K.; Toomre, D. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 2000, 1, 31-39.
26. Hancock, J.F. Lipid rafts: Contentious only from simplistic standpoints. Nat. Rev. Mol. Cell Biol. 2006, 7, 456-462.
27. Cordy, J.M.; Hooper, N.M.; Turner, A.J. The involvement of lipid rafts in Alzheimer's disease. Mol. Membr. Biol. 2006, 23, 111-122.
28. Kayed, R.; Pensalfini, A.; Margol, L.; Sokolov, Y.; Sarsoza, F.; Head, E.; Hall, J.; Glabe, C. Annular protofibrils are a structurally and functionally distinct type of amyloid oligomer. J. Biol. Chem. 2009, 284, 4230-4237.
29. Chesnut, C.H., 3rd; Azria, M.; Silverman, S.; Engelhardt, M.; Olson, M.; Mindeholm, L. Salmon calcitonin: A review of current and future therapeutic indications. Osteoporos. Int. 2008, 19, 479-491.
30. Breimer, L.H.; MacIntyre, I.; Zaidi, M. Peptides from the calcitonin genes: Molecular genetics, structure and function. Biochem. J. 1988, 255, 377-390.
31. Cafforio, P.; de Matteo, M.; Brunetti, A.E.; Dammacco, F.; Silvestris, F. Functional expression of the calcitonin receptor by human T and B cells. Hum. Immunol. 2009, 70, 678-685.
32. Bauer, H.H.; Aebi, U.; Haner, M.; Hermann, R.; Muller, M.; Merkle, H.P. Architecture and polymorphism of fibrillar supramolecular assemblies produced by in vitro aggregation of human calcitonin. J. Struct. Biol. 1995, 115, 1-15.
33. Arvinte, T.; Cudd, A.; Drake, A.F. The structure and mechanism of formation of human calcitonin fibrils. J. Biol. Chem. 1993, 268, 6415-6422.
34. Arvinte, T.; Drake, A.F. Comparative study of human and salmon calcitonin secondary structure in solutions with low dielectric constants. J. Biol. Chem. 1993, 268, 6408-6414.
35. Ferrone, F.A.; Hofrichter, J.; Sunshine, H.R.; Eaton, W.A. Kinetic studies on photolysis-induced gelation of sickle cell hemoglobin suggest a new mechanism. Biophys. J. 1980, 32, 361-380.
36. Meyer, J.P.; Pelton, J.T.; Hoflack, J.; Saudek, V. Solution structure of salmon calcitonin. Biopolymers 1991, 31, 233-241.
37. Epand, R.M.; Epand, R.F.; Orlowski, R.C.; Schlueter, R.J.; Boni, L.T.; Hui, S.W. Amphipathic helix and its relationship to the interaction of calcitonin with phospholipids. Biochemistry 1983, 22, 5074-5084.
38. Gilchrist, P.J.; Bradshaw, J.P. Amyloid formation by salmon calcitonin. Biochim. Biophys. Acta 1993, 1182, 111-114.
39. Gaudiano, M.C.; Diociaiuti, M.; Bertocchi, P.; Valvo, L. Effects induced by hydroxyl radicals on salmon calcitonin: A RP-HPLC, CD and TEM study. Biochim. Biophys. Acta 2003, 1623, 33-40.
40. Siligardi, G.; Samori, B.; Melandri, S.; Visconti, M.; Drake, A.F. Correlations between biological activities and conformational properties for human, salmon, eel, porcine calcitonins and elcatonin elucidated by CD spectroscopy. Eur. J. Biochem. 1994, 221, 1117-1125.
41. van der Zee, J.; Krootjes, B.B.; Chignell, C.F.; Dubbelman, T.M.; Van Steveninck, J. Hydroxyl radical generation by a light-dependent Fenton reaction. Free Radic. Biol. Med. 1993, 14, 105-113.
42. Gaudiano, M.C.; Colone, M.; Bombelli, C.; Chistolini, P.; Valvo, L.; Diociaiuti, M. Early stages of salmon calcitonin aggregation: Effect induced by ageing and oxidation processes in water and in the presence of model membranes. Biochim. Biophys. Acta 2005, 1750, 134-145.
43. Halliwell, B. Free radicals, antioxidants, and human disease: Curiosity, cause, or consequence? Lancet 1994, 344, 721-724.
44. Halliwell, B.; Gutteridge, J.M.; Cross, C.E. Free radicals, antioxidants, and human disease: Where are we now? J. Lab. Clin. Med. 1992, 119, 598-620.
45. Diociaiuti, M.; Molinari, A.; Ruspantini, I.; Gaudiano, M.C.; Ippoliti, R.; Lendaro, E.; Bordi, F.; Chistolini, P.; Arancia, G. P-glycoprotein inserted in planar lipid bilayers formed by liposomes opened on amorphous carbon and langmuir-blodgett monolayer. Biochim. Biophys. Acta 2002, 1559, 21-31.
46. Bradshaw, J.P. Phosphatydylglycerol promotes bilayer insertion of salmon calcitonin. Biophys. J. 1997, 72, 2180-2186.
47. Diociaiuti, M.; Polzi, L.Z.; Valvo, L.; Malchiodi-Albedi, F.; Bombelli, C.; Gaudiano, M.C. Calcitonin forms oligomeric pore-like structures in lipid membranes. Biophys. J. 2006, 91, 2275-2281.
48. Malchiodi-Albedi, F.; Contrusciere, V.; Raggi, C.; Fecchi, K.; Rainaldi, G.; Paradisi, S.; Matteucci, A.; Santini, M.T.; Sargiacomo, M.; Frank, C.; et al. Lipid raft disruption protects mature neurons against amyloid oligomer toxicity. Biochim. Biophys. Acta 2010, 1802, 406-415.
49. Ledesma, M.D.; Brugger, B.; Bunning, C.; Wieland, F.T.; Dotti, C.G. Maturation of the axonal plasma membrane requires upregulation of sphingomyelin synthesis and formation of protein-lipid complexes. EMBO J. 1999, 18, 1761-1771.